DNA Brands Financials
| DNAX Stock | USD 0.0001 0.00 0.00% |
DNA |
Understanding current and past DNA Brands Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of DNA Brands' financial statements are interrelated, with each one affecting the others. For example, an increase in DNA Brands' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in DNA Brands' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of DNA Brands. Check DNA Brands' Beneish M Score to see the likelihood of DNA Brands' management manipulating its earnings.
DNA Brands Stock Summary
DNA Brands competes with Keurig Dr, Zevia Pbc, Vita Coco, and National Beverage. It offers products in various flavors, such as cellular citrus zero sugar, cellular citrus, cryo berry, and molecular melon. DNA Brands, Inc. also owns TokenTalk.io, an advisory firm for companies looking to raise money through an ICO. Dna Brands operates under BeveragesNon-Alcoholic classification in the United States and is traded on OTC Exchange. It employs 1 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US23328Q3074 |
| Business Address | 6245 N Federal |
| Sector | Beverages |
| Industry | Consumer Staples |
| Benchmark | Dow Jones Industrial |
| Website | www.dnabrandsinc.com |
| Phone | 954 368 3272 |
| Currency | USD - US Dollar |
DNA Brands Key Financial Ratios
DNA Brands' financial ratios allow both analysts and investors to convert raw data from DNA Brands' financial statements into concise, actionable information that can be used to evaluate the performance of DNA Brands over time and compare it to other companies across industries.DNA Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DNA Brands's current stock value. Our valuation model uses many indicators to compare DNA Brands value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DNA Brands competition to find correlations between indicators driving DNA Brands's intrinsic value. More Info.DNA Brands is rated below average in operating margin category among its peers. It also is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value DNA Brands by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for DNA Brands' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.DNA Brands Systematic Risk
DNA Brands' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. DNA Brands volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on DNA Brands correlated with the market. If Beta is less than 0 DNA Brands generally moves in the opposite direction as compared to the market. If DNA Brands Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one DNA Brands is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of DNA Brands is generally in the same direction as the market. If Beta > 1 DNA Brands moves generally in the same direction as, but more than the movement of the benchmark.
DNA Brands November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of DNA Brands help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of DNA Brands. We use our internally-developed statistical techniques to arrive at the intrinsic value of DNA Brands based on widely used predictive technical indicators. In general, we focus on analyzing DNA Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build DNA Brands's daily price indicators and compare them against related drivers.
| Downside Deviation | 52.7 | |||
| Information Ratio | 0.1436 | |||
| Maximum Drawdown | 150.0 | |||
| Value At Risk | (50.00) | |||
| Potential Upside | 100.0 |
Additional Tools for DNA Pink Sheet Analysis
When running DNA Brands' price analysis, check to measure DNA Brands' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNA Brands is operating at the current time. Most of DNA Brands' value examination focuses on studying past and present price action to predict the probability of DNA Brands' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNA Brands' price. Additionally, you may evaluate how the addition of DNA Brands to your portfolios can decrease your overall portfolio volatility.